Results 121 to 130 of about 17,111 (223)

Burosumab for adults with tumor-induced osteomalacia in China

Endocrine Connections
A better understanding of the benefit of burosumab for treating tumor-induced osteomalacia (TIO) in Chinese patients is needed. The objective of this open-label, multicenter, single-cohort, post-marketing phase 4 study was to assess the efficacy ...
Ruizhi Jiajue, Chunyan Lu, Jiemei Gu, Maiko Sugimoto, Chinwei Yung, Masaaki Kuriki, Zhenlin Zhang, Weibo Xia   +7 more
doaj   +1 more source

FGF23 and bone microarchitecture [PDF]

Osteoporosis International, 2019
T, Rupp, M, Amling, T, Rolvien
openaire   +2 more sources

FGF23 induces left ventricular hypertrophy.

Journal of Clinical Investigation, 2011
C. Faul, A. Amaral, Behzad N. Oskouei, M. Hu, A. Sloan, T. Isakova, O. Gutiérrez, Robier Aguillon-Prada, J. Lincoln, J. Hare, P. Mundel, Azorides R. Morales, J. Scialla, M. Fischer, E. Soliman, J. Chen, A. Go, S. Rosas, L. Nessel, R. Townsend, H. Feldman, M. G. St. John Sutton, A. Ojo, C. Gadegbeku, G. D. Di Marco, S. Reuter, Dominik Kentrup, K. Tiemann, M. Brand, Joseph A. Hill, O. Moe, M. Kuro-o, J. Kusek, M. Keane, M. Wolf   +34 more
semanticscholar   +1 more source

FGF23 modulates the effects of erythropoietin on gene expression in renal epithelial cells

International Journal of Nephrology and Renovascular Disease, 2018
Mitsuru Yashiro,1 Masaki Ohya,1 Toru Mima,1 Yumi Ueda,2 Yuri Nakashima,1 Kazuki Kawakami,1 Yohei Ishizawa,2 Shuto Yamamoto,1 Sou Kobayashi,1 Takurou Yano,1 Yusuke Tanaka,1 Kouji Okuda,1 Tomohiro Sonou,1 Tomohiro Shoshihara,1 Yuko Iwashita,1 Yu Iwashita,1
Yashiro M, Ohya M, Mima T, Ueda Y, Nakashima Y, Kawakami K, Ishizawa Y, Yamamoto S, Kobayashi S, Yano T, Tanaka Y, Okuda K, Sonou T, Shoshihara T, Iwashita Y, Iwashita Y, Tatsuta K, Matoba R, Negi S, Shigematsu T   +19 more
doaj  

Exercising the FGF23-Cardiac Axis

Kidney360, 2022
Susan L. Murray, Myles Wolf
openaire   +2 more sources

Hypophosphatemic rickets: diagnosis and treatment. [PDF]

Arch Endocrinol Metab
Bruneau H, Bergwitz C.
europepmc   +1 more source

Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophy. [PDF]

Kidney Int
Kentrup D, Thomas JJ, Courbon G, Wang X, Hunt-Tobey B, White S, Duque EJ, Semanchek W, Tracey E, Kumar R, Isakova T, David V, Martin A.   +12 more
europepmc   +1 more source

Three-Phase Serum Concentration Kinetics of FGF23 in a Clinical Model of Acute Myocardial Infarction. [PDF]

Cells
Strack N, Gajawada P, Liebetrau C, Dörr O, Keller T, Choi YH, Richter M.   +6 more
europepmc   +1 more source

FGF23 and Immune Cell Signatures Causally Linked to Subarachnoid Hemorrhage: Evidence From Multi-Omics and Genetic Colocalization. [PDF]

Brain Behav
Shi X, Zhang C, Yang T, Sun Z, Wang C, Zhou L, Hou S, Lin N, Zhang L.   +8 more
europepmc   +1 more source

Modeling Longitudinal Relationships Between CKD-MBD Biomarker Trajectories with Interpretable Machine Learning in a Large Prospective CKD Cohort. [PDF]

J Clin Med
Taskapan T, Taskapan H, Bellasi A, Mahdavi S, Ma H, Tam P, Sikaneta T.   +6 more
europepmc   +1 more source